BE885368A - Compositions pharmaceutiques pour le traitement des complications associees au diabete - Google Patents

Compositions pharmaceutiques pour le traitement des complications associees au diabete

Info

Publication number
BE885368A
BE885368A BE0/202210A BE202210A BE885368A BE 885368 A BE885368 A BE 885368A BE 0/202210 A BE0/202210 A BE 0/202210A BE 202210 A BE202210 A BE 202210A BE 885368 A BE885368 A BE 885368A
Authority
BE
Belgium
Prior art keywords
diabetes
treatment
pharmaceutical compositions
complications associated
complications
Prior art date
Application number
BE0/202210A
Other languages
English (en)
Inventor
D Dvornik
Duquesne N Simard
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of BE885368A publication Critical patent/BE885368A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/202210A 1980-06-19 1980-09-24 Compositions pharmaceutiques pour le traitement des complications associees au diabete BE885368A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/160,873 US4307114A (en) 1980-06-19 1980-06-19 Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid

Publications (1)

Publication Number Publication Date
BE885368A true BE885368A (fr) 1981-03-24

Family

ID=22578828

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202210A BE885368A (fr) 1980-06-19 1980-09-24 Compositions pharmaceutiques pour le traitement des complications associees au diabete

Country Status (6)

Country Link
US (2) US4307114A (fr)
JP (1) JPS5775919A (fr)
AU (1) AU546900B2 (fr)
BE (1) BE885368A (fr)
PH (1) PH15830A (fr)
ZA (1) ZA814136B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4028772A (en) * 1971-04-02 1973-09-27 Merck & Co., Inc Chemical processes
US4880835A (en) * 1988-11-03 1989-11-14 Formulations Development Labs, Inc. Oral liquid pharmaceutical compositions of sulindac
US5998477A (en) * 1996-06-13 1999-12-07 Cell Pathways Inc. Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
US6063818A (en) * 1996-06-13 2000-05-16 Cell Pathways Inc. Substituted benzylidene indenyl formamides, acetamides and propionamides
US5965619A (en) * 1996-06-13 1999-10-12 Cell Pathways Inc. Method for treating patients having precancerous lesions with substituted indene derivatives
US6121321A (en) * 1996-06-13 2000-09-19 Cell Pathways, Inc. Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions
US5948779A (en) * 1997-12-12 1999-09-07 Cell Pathways, Inc. Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes
US6028116A (en) * 1998-04-03 2000-02-22 Cell Pathways, Inc. Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
KR100430428B1 (ko) * 2001-10-04 2004-05-04 학교법인 가톨릭학원 설린닥을 함유하는 망막 손상 치료용 안약 조성물과 그제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654349A (en) * 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
US3647858A (en) * 1970-05-01 1972-03-07 Merck & Co Inc Process for preparing 1-benzylidene-3-indenyl acetic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen

Also Published As

Publication number Publication date
PH15830A (en) 1983-04-08
JPS5775919A (en) 1982-05-12
AU546900B2 (en) 1985-09-26
ZA814136B (en) 1982-08-25
US4423074A (en) 1983-12-27
US4307114A (en) 1981-12-22
AU7135881A (en) 1981-12-24

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
BE849416A (fr) Composition anti-moussage pour le traitement de denrees alimentaires
FR2320971A1 (fr) Procede pour le traitement d'un pigment au bioxyde de titane
FR2333515A1 (fr) Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2482588B1 (fr) Composition pharmaceutique pour le traitement du diabete sucre juvenile
BE885368A (fr) Compositions pharmaceutiques pour le traitement des complications associees au diabete
FR2307909A1 (fr) Compositions pour le traitement des etoffes
FR2341315A1 (fr) Medicaments pour le traitement des neuropathies
BE873092A (fr) Composition pour le traitement de l'hypertension
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE820222A (fr) Composition therapeutique pour le traitement du diabete par voie orale
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete
RO86562A2 (fr) Composition vegetale medicamenteuse pour le traitement des affectionsbiliares
BE837294A (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
BE812974A (fr) Compositions pharmaceutiques pour le traitement des ulceres

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: AYERST MCKENNA & HARRISON INC.

Effective date: 19880930